Though Pfizer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Experts say there's no proven link between stiff person syndrome and the COVID-19 vaccine.

ReCode Therapeutics closed an $80 million Series B round of financing that included Pfizer and Sanofi as investors. The startup’s technology uses lipid nanoparticles to deliver genetic medicines, and its two lead programs are for rare lung disorders.

(GlaxoSmithKline) A drug that Pfizer passed over but saw a revitalized cancer R&D-focused GlaxoSmithKline jump on for $4.2 billion has come up as a dud in a key trial pitting it against U.S. Merck’s blockbuster Keytruda. That drug, originally known as M7824, now bintrafusp alfa, works as a bifunctional fusion protein immunotherapy. It is designed to combine a TGF-β trap with the anti-PD-L1 mechanism in one fusion protein and to combine co-localized blocking of the two immuno-suppressive pathways: Targeting both pathways aims to control tumor growth by potentially restoring and en...

Dr. Fauci on his proudest moment from the pandemic so far — and the darkest CNBC 12/15/2020 Cory Stieg © Provided by CNBC Director of the National Institute of Allergy and Infectious Diseases Anthony Fauci speaks with Vice President Mike Pence as they participate in a news briefing with member of the White House Coronavirus Task Force in the James S. Brady Press Briefing Room at the White House on Thursday, Nov 19, 2020 in Washington, DC. In so many ways, the year 2020 has been defined by the Covid-19 pandemic. This is especially true for Dr. Anthony Fauci, the nation's...